PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced progress in its ongoing evaluation of strategic alternatives, which was announced on November 13, 2024.
Read more at globenewswire.comPredictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
PREDICTIVE ONCOLOGY INC
NASDAQ:POAI (2/11/2025, 2:47:56 PM)
1.42
-0.01 (-0.7%)
POAI Latest News and Analysis
20 days ago - ChartmillGapping stocks in Wednesday's sessionLet's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
